Atrophy and dysfunction of parahippocampal white matter in mild Alzheimer's disease

Changsheng Wang1, Glenn T Stebbins, David A Medina

  • 1Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA. cwang30@emory.edu

Neurobiology of Aging
|April 3, 2010
PubMed

Insights

Mild Alzheimer's disease (AD) damages parahippocampal white matter (PWM), affecting memory. This study found PWM volume loss and microstructural changes in AD patients, linked to memory decline and ApoE ε4 status.

Area of Science:

  • Neuroimaging
  • Neurodegenerative Diseases
  • Alzheimer's Disease Research

Background:

  • Memory impairment in mild Alzheimer's disease (AD) is linked to hippocampal atrophy.
  • White matter pathways connecting to the hippocampus may also be affected, worsening memory deficits.

Purpose of the Study:

  • To investigate microstructural alterations in the parahippocampal white matter (PWM) in individuals with mild AD.
  • To correlate these changes with memory performance and apolipoprotein E (ApoE) ε4 allele status.

Main Methods:

  • Utilized high-resolution structural imaging and diffusion tensor imaging (DTI).
  • Examined microstructural integrity and volume of the PWM, including the perforant path.

Main Results:

  • Mild AD patients exhibited bilateral PWM volume loss.
  • Reduced fractional anisotropy and increased mean diffusivity were observed in the remaining PWM.
  • PWM volume reduction and increased mean diffusivity correlated with poorer memory performance and ApoE ε4 allele presence.

Conclusions:

  • PWM volume loss and microstructural fiber damage contribute to hippocampal disconnection and memory dysfunction in mild AD.
  • These findings suggest that ApoE ε4 may worsen PWM alterations in Alzheimer's disease.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Role of Hippocampus in Memory01:19

Role of Hippocampus in Memory

The hippocampus, a critical brain structure, plays an essential role in memory processing, particularly in the formation and retrieval of memory. This small, seahorse-shaped region is located within the medial temporal lobe, with one hippocampus in each brain hemisphere. Experimental studies involving lesions in the hippocampi of rats have demonstrated significant impairments in tasks such as object recognition and maze navigation, indicating the hippocampus involvement in both recognition and...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...